nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—Hypotension—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Brinzolamide—Rash—Bleomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Brinzolamide—Pain—Cisplatin—testicular cancer	0.00158	0.00158	CcSEcCtD
Brinzolamide—Dermatitis—Bleomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Brinzolamide—Hypersensitivity—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Brinzolamide—Asthenia—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—testicular cancer	0.00152	0.00152	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Brinzolamide—Pruritus—Ifosfamide—testicular cancer	0.00152	0.00152	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Brinzolamide—Nausea—Bleomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—testicular cancer	0.00149	0.00149	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Brinzolamide—Diarrhoea—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Brinzolamide—Pain—Etoposide—testicular cancer	0.00145	0.00145	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Brinzolamide—Dizziness—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Brinzolamide—Vomiting—Ifosfamide—testicular cancer	0.00136	0.00136	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—testicular cancer	0.00136	0.00136	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Brinzolamide—Rash—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Brinzolamide—Dermatitis—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Brinzolamide—Nausea—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—testicular cancer	0.00126	0.00126	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—testicular cancer	0.0012	0.0012	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Brinzolamide—Rash—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Brinzolamide—Tension—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—testicular cancer	0.0011	0.0011	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Brinzolamide—Cough—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Brinzolamide—Rash—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Brinzolamide—Headache—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Brinzolamide—Cough—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Brinzolamide—Infection—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Brinzolamide—Nausea—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000997	0.000997	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—testicular cancer	0.000993	0.000993	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—testicular cancer	0.000989	0.000989	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—testicular cancer	0.000984	0.000984	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—testicular cancer	0.000977	0.000977	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—testicular cancer	0.000969	0.000969	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—testicular cancer	0.000967	0.000967	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—testicular cancer	0.00095	0.00095	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—testicular cancer	0.000947	0.000947	CcSEcCtD
Brinzolamide—Infection—Epirubicin—testicular cancer	0.000942	0.000942	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—testicular cancer	0.00093	0.00093	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—testicular cancer	0.000928	0.000928	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—testicular cancer	0.000925	0.000925	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000923	0.000923	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—testicular cancer	0.000916	0.000916	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—testicular cancer	0.00091	0.00091	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—testicular cancer	0.000904	0.000904	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—testicular cancer	0.000903	0.000903	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—testicular cancer	0.000901	0.000901	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—testicular cancer	0.000895	0.000895	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—testicular cancer	0.000892	0.000892	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—testicular cancer	0.000886	0.000886	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—testicular cancer	0.000881	0.000881	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000875	0.000875	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—testicular cancer	0.000873	0.000873	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—testicular cancer	0.000871	0.000871	CcSEcCtD
Brinzolamide—Pain—Methotrexate—testicular cancer	0.000866	0.000866	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—testicular cancer	0.000856	0.000856	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—testicular cancer	0.000835	0.000835	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—testicular cancer	0.000824	0.000824	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Brinzolamide—Pain—Epirubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—testicular cancer	0.000805	0.000805	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—testicular cancer	0.000788	0.000788	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—testicular cancer	0.000782	0.000782	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—testicular cancer	0.000781	0.000781	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—testicular cancer	0.000746	0.000746	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—testicular cancer	0.000727	0.000727	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000723	0.000723	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—testicular cancer	0.000717	0.000717	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—testicular cancer	0.000693	0.000693	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—testicular cancer	0.00067	0.00067	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—testicular cancer	0.000649	0.000649	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—testicular cancer	0.000644	0.000644	CcSEcCtD
Brinzolamide—Rash—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Brinzolamide—Headache—Methotrexate—testicular cancer	0.000635	0.000635	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—testicular cancer	0.000629	0.000629	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—testicular cancer	0.000602	0.000602	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—testicular cancer	0.0006	0.0006	CcSEcCtD
Brinzolamide—Rash—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Brinzolamide—Headache—Epirubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—testicular cancer	0.000563	0.000563	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
